vimarsana.com

Page 7 - Visual Acuity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

OCTA-based Assessment of Diabetic Macular Ischemia May Help Evaluate DR Progression

The findings could provide insight into incorporating both OCTA and artificial intelligence for early detection of DMI and better enhancing the management of diabetic retinopathy.

Hong kongUniversity of hong kongHong kong generalCaroly cheungChinese universityHong kong eye centerHong kong eyeParafoveal diabetic macular ischemiaOptical coherence tomography angiography imagesPredict diabetic retinal disease progressionVisual acuityProg retin eye

Tunable Lenses Offer New Way to Correct Presbyopia

Adaptive liquid crystal lenses can be electrically tuned to any optical power, according to researchers.

Israel generalRavid doronAssociation for researchHadassah academic collegeDeep opticsMedscape medicalRefractive errorVision care and maintenanceField of visionVisual acuityOcular allergiesLlergic eye diseasesLlergic ophthalmologic conditions

Uncontrolled Wet AMD: Drug Switch Can Mute Disease Activity

Phase 3 data from the 2023 ARVO meeting showed treatment with the monoclonal antibody improved visual acuity in some patients.

France generalNew south walesRamin tadayoniMark gilliesBrolucizumab beovuIveric bioSrinivasr saddaDoheny eye instituteUniversity of parisAssociation for researchMacula research groupUniversity of sydney save sight instituteSaint louis university hospitalsCalifornia los angeles david geffen schoolDrug administrationSydney save sight

Early Anti-VEGF Isn t Worth Cost in Diabetic Retinopathy

A drug tested on patients with nonproliferative diabetic retinopathy did not improve vision outcomes.

United statesSamsung bioepisEli lillyNimesh patelLee jampolMidwest eye institute in indianapolisJaeb centerRetina networkHealth researchNorthwestern university feinberg school of medicineRegeneron pharmaceuticalsAssociation for researchBoehringer ingelheimRaj maturiMidwest eye instituteMedscape medical

Pixium Vision announces its consolidated financial

Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31, 2023 .

United statesUnited kingdomFrance generalComunidad autonoma de catalunaNordrhein westfalenCity ofEntreprise innovanteGuillaume van renterghemSophie baumontInstitute of ocular microsurgeryResearch tax creditPixium visionEuronext growth parisSecond sight medicalNext generationBreakthrough device designation

vimarsana © 2020. All Rights Reserved.